StemCell Therapy

New Jersey, United States:The Nanoparticles in Biotechnology and Pharmaceuticals Market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the Nanoparticles in Biotechnology and Pharmaceuticals market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the Nanoparticles in Biotechnology and Pharmaceuticals Market. With qualitative and quantitative analysis, we help you with thorough and comprehensive research on the Nanoparticles in Biotechnology and Pharmaceuticals market. We have also focused on SWOT, PESTLE, and Porters Five Forces analyses of the Nanoparticles in Biotechnology and Pharmaceuticals market.

The main players featured in the Nanoparticles in Biotechnology and Pharmaceuticals market report are:

Leading players of the Nanoparticles in Biotechnology and Pharmaceuticals market are analyzed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. We also provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the Nanoparticles in Biotechnology and Pharmaceuticals market. Furthermore, the report offers two separate market forecasts one for the production side and another for the consumption side of the Nanoparticles in Biotechnology and Pharmaceuticals market. It also provides useful recommendations for new as well as established players of the Nanoparticles in Biotechnology and Pharmaceuticals market.

Nanoparticles in Biotechnology and Pharmaceuticals Market by Regional Segments:

The chapter on regional segmentation describes the regional aspects of the Nanoparticles in Biotechnology and Pharmaceuticals market. This chapter explains the regulatory framework that is expected to affect the entire market. It illuminates the political scenario of the market and anticipates its impact on the market for Nanoparticles in Biotechnology and Pharmaceuticals.

Analysts who have authored the report have segmented the market for Nanoparticles in Biotechnology and Pharmaceuticals by product, application and region. All segments are the subject of extensive research, with a focus on CAGR, market size, growth potential, market share and other important factors. The segment study provided in the report will help players focus on the lucrative areas of the Nanoparticles in Biotechnology and Pharmaceuticals market. The regional analysis will help the actors to strengthen their position in the most important regional markets. It shows unused growth opportunities in regional markets and how they can be used in the forecast period.

Ask for Discount @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=19246&utm_source=SGN&utm_medium=003

Highlights of TOC:

Overview: In addition to an overview of the Nanoparticles in Biotechnology and Pharmaceuticals market, this section provides an overview of the report to give an idea of the type and content of the study.

Market dynamics: Here the authors of the report discussed in detail the main drivers, restrictions, challenges, trends and opportunities in the market for Nanoparticles in Biotechnology and Pharmaceuticals.

Product Segments: This part of the report shows the growth of the market for various types of products sold by the largest companies.

Application segments: The analysts who have authored the report have thoroughly evaluated the market potential of the key applications and identified the future opportunities they should create in the Nanoparticles in Biotechnology and Pharmaceuticals.

Geographic Segments: Each regional market is carefully examined to understand its current and future growth scenarios.

Company Profiles: The top players in the Nanoparticles in Biotechnology and Pharmaceuticals market are detailed in the report based on their market share, served market, products, applications, regional growth and other factors.

The report also includes specific sections on production and consumption analysis, key results, key suggestions and recommendations, and other issues. Overall, it offers a complete analysis and research study of the Nanoparticles in Biotechnology and Pharmaceuticals market to help players ensure strong growth in the coming years.

Complete Report is Available @ https://www.verifiedmarketresearch.com/product/Nanoparticles-in-Biotechnology-and-Pharmaceuticals-Market/?utm_source=SGN&utm_medium=003

About us:

Verified market research partners with the customer and offer an insight into strategic and growth analyzes; Data necessary to achieve corporate goals and objectives. Our core values are trust, integrity and authenticity for our customers.

Analysts with a high level of expertise in data collection and governance use industrial techniques to collect and analyze data in all phases. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research reports.

Contact us:

Mr. Edwyne FernandesCall: +1 (650) 781 4080Email: [emailprotected]

Tags: Nanoparticles in Biotechnology and Pharmaceuticals Market Size, Nanoparticles in Biotechnology and Pharmaceuticals Market Trends, Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast, Nanoparticles in Biotechnology and Pharmaceuticals Market Growth, Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis

Our Trending Reports

Nanoparticles in Biotechnology and Pharmaceuticals Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Read the original here:
Nanoparticles in Biotechnology and Pharmaceuticals Market 2020 | Growing Rapidly with Significant CAGR, Leading Players, Innovative Trends and...

New Jersey, United States:The Agricultural Biotechnology Market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the Agricultural Biotechnology market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the Agricultural Biotechnology Market. With qualitative and quantitative analysis, we help you with thorough and comprehensive research on the Agricultural Biotechnology market. We have also focused on SWOT, PESTLE, and Porters Five Forces analyses of the Agricultural Biotechnology market.

Global Agricultural Biotechnology Market was valued at USD 35.6 Billion in 2018 and is projected to reach USD 74.92 Billion by 2026, growing at a CAGR of 9.70% from 2019 to 2026.

Get | Download Sample Copy @ https://www.verifiedmarketresearch.com/download-sample/?rid=35624&utm_source=SGN&utm_medium=009

The main players featured in the Agricultural Biotechnology market report are:

Leading players of the Agricultural Biotechnology market are analyzed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. We also provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the Agricultural Biotechnology market. Furthermore, the report offers two separate market forecasts one for the production side and another for the consumption side of the Agricultural Biotechnology market. It also provides useful recommendations for new as well as established players of the Agricultural Biotechnology market.

Agricultural Biotechnology Market by Regional Segments:

The chapter on regional segmentation describes the regional aspects of the Agricultural Biotechnology market. This chapter explains the regulatory framework that is expected to affect the entire market. It illuminates the political scenario of the market and anticipates its impact on the market for Agricultural Biotechnology.

Analysts who have authored the report have segmented the market for Agricultural Biotechnology by product, application and region. All segments are the subject of extensive research, with a focus on CAGR, market size, growth potential, market share and other important factors. The segment study provided in the report will help players focus on the lucrative areas of the Agricultural Biotechnology market. The regional analysis will help the actors to strengthen their position in the most important regional markets. It shows unused growth opportunities in regional markets and how they can be used in the forecast period.

Ask for Discount @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=35624&utm_source=SGN&utm_medium=009

Highlights of TOC:

Overview: In addition to an overview of the Agricultural Biotechnology market, this section provides an overview of the report to give an idea of the type and content of the study.

Market dynamics: Here the authors of the report discussed in detail the main drivers, restrictions, challenges, trends and opportunities in the market for Agricultural Biotechnology.

Product Segments: This part of the report shows the growth of the market for various types of products sold by the largest companies.

Application segments: The analysts who have authored the report have thoroughly evaluated the market potential of the key applications and identified the future opportunities they should create in the Agricultural Biotechnology.

Geographic Segments: Each regional market is carefully examined to understand its current and future growth scenarios.

Company Profiles: The top players in the Agricultural Biotechnology market are detailed in the report based on their market share, served market, products, applications, regional growth and other factors.

The report also includes specific sections on production and consumption analysis, key results, key suggestions and recommendations, and other issues. Overall, it offers a complete analysis and research study of the Agricultural Biotechnology market to help players ensure strong growth in the coming years.

Complete Report is Available @ https://www.verifiedmarketresearch.com/product/agricultural-biotechnology-market/?utm_source=SGN&utm_medium=009

About us:

Verified market research partners with the customer and offer an insight into strategic and growth analyzes; Data necessary to achieve corporate goals and objectives. Our core values are trust, integrity and authenticity for our customers.

Analysts with a high level of expertise in data collection and governance use industrial techniques to collect and analyze data in all phases. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research reports.

Contact us:

Mr. Edwyne FernandesCall: +1 (650) 781 4080Email: [emailprotected]

Tags: Agricultural Biotechnology Market Size, Agricultural Biotechnology Market Trends, Agricultural Biotechnology Market Forecast, Agricultural Biotechnology Market Growth, Agricultural Biotechnology Market Analysis

Our Trending Reports

Threat Intelligence Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

See the original post here:
Agricultural Biotechnology Market 2020 | Growing Rapidly with Significant CAGR, Leading Players, Innovative Trends and Expected Revenue by 2026 -...

Global Agriculture Biotechnology Market 2019, this report is prepared by in-depth analysis of historical data. The report forecasts the market size by the end of 2026 at an impressive CAGR provided by Reports and Reports. The report offers detailed outline of Agriculture Biotechnology Market and vital market trends. The prime agenda of this report is to provide a detailed analysis of the global, regional and country-level market size, market growth, market status, forecast, sales analysis, value chain optimization, trade regulations, recent developments, opportunities analysis, and importance of the global and national market players, competitive environment, expansion, acquisition, partnerships and technological innovations. The prime market segments considered to prepare this report are key players, regional segments, type and application.

Get Free Sample Copy of Agriculture Biotechnology Market: http://www.milliondollarresearch.com/agriculture-biotechnology-market/955/#RequestSample

The Agriculture Biotechnology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The major players covered in Agriculture Biotechnology Market are: ADAMA Agricultural Solutions, Vilmorin, Bayer, Biocentury Transgene, Certis, Dow AgroSciences, Eurofins, Evogene, Global Bio-chem Technology, Syngenta, KWS Saat, Marina Biotech, Monsanto.

Agriculture Biotechnology Industry 2020 Global Market Research report presents an in-depth analysis of the Agriculture Biotechnology market size, growth, share, segments, manufacturers, and technologies, key trends, market drivers, challenges, standardization, deployment models, opportunities, future roadmap and 2026 forecast. The report additionally presents forecasts for Agriculture Biotechnology market revenue, consumption, production, and growth drivers of the market.

Get Special Discount on this report: http://www.milliondollarresearch.com/agriculture-biotechnology-market/955/#AskForDiscount

Regions and Countries Level Analysis:

The important regions, considered to prepare this report are North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa). The region wise data analyses the trend, market size of each regions Agriculture Biotechnology Market.

Table of Content (TOC)

Chapter 1: Product definition, type and application, Global market overview;

Chapter 2: Global Market competition by company;

Chapter 3: Global sales revenue, volume and price by type;

Chapter 4: Global sales revenue, volume and price by application;

Chapter 5: United States export and import;

Chapter 6: Company information, business overview, sales data and product specifications;

Chapter 7: Industry chain and raw materials;

Chapter 8: SWOT and Porters Five Forces;

Chapter 9: Conclusion.

Continue

List of Tables and Figures

Get Detail information of this report: http://www.milliondollarresearch.com/agriculture-biotechnology-market/955/

Conclusively, this report is a one stop reference point for the industrial stakeholders to get Agriculture Biotechnology Market forecast of till 2026. This report helps to know the estimated market size, market status, future development, growth opportunity, challenges, growth drivers of by analyzing the historical overall data of the considered market segments.

Follow this link:
Global Agriculture Biotechnology Market Expected to Witness the Highest Growth with ADAMA Agricultural Solutions, Vilmorin, Bayer, Biocentury...

Text Size:A- A+

New Delhi:A leading scientist at the International Centre for Genetic Engineering and Biotechnology (ICGEB) in New Delhi has found that valproic acid, an anti-epilepsy drug, can be repurposed and used for acute cases of Covid-19.

The scientist, Neel Sarovar Bhavesh, has written to the director general of the Indian Council of Medical Research (ICMR), the apex body in the field, to test valproic acid at the National Institute of Virology in Pune or any ICMR lab to find a quick solution to the coronavirus crisis.

The ICGEB is part of the research consortium working to find a cure and vaccine for Covid-19.

Valproic acid is an approved drug, whose patent expired recently. It is sold under brand names such as Depacon and Stavzor to treat epilepsy. The University of California has also validated the ICGEBs research findings it lists valproic acid as one of the molecules for repurposing and testing for use against the Covid-19 virus.

Also read: AI identifies potential drugs and a DNA vaccine in the works latest on Covid-19

Bhavesh, the head of transcriptional regulation at ICGEB, told ThePrint: We have performed high-throughput virtual screening (HTVS) of 1.2 million small molecules from the four databases, and later performed Energy calculation and molecular binding simulation. We found that valproic acid CoA may be repurposed to inhibit the RNA-dependent RNA polymerase of the virus.

We have written to the DG ICMR to test this molecule on cell culture and animal testing facilities, in combination with potent binding blocking molecules. Currently no one in India outside the NIV and ICMR has access to the Covid-19 virus, Bhavesh said.

About 1,100 strains of the novel coronavirus have been sequenced from around the world. We (in India) have around 700 confirmed positive cases, but only two virus sequences are available at the NIV. These sequences are different from each other, he explained.

Bhavesh revealed that after the publication of the ICGEB research, multinational pharmaceutical company GlaxoSmithKline contacted them.

However, Bhavesh said theres an urgent need for cooperation from government bodies like the ICMR and the NIV in terms of giving researchers access to the virus strains in India to test on.

There should be synchronisation in testing and developing. If NIV or any another research institution finds success, lots of patients can be cured and saved. The need of the hour is to find the solution. The NIV must cooperate with other institutions more generously, he said.

A day before, Union Biotechnology Secretary Renu Swarup also said in an interview that early solutions for the novel coronavirus can be found from repurposed drugs, and that developing new drugs would take time.

Also read: Old drugs, new trials hopes pinned on HIV, malaria, ebola, TB vaccines to fight Covid-19

ThePrint is now on Telegram. For the best reports & opinion on politics, governance and more, subscribe to ThePrint on Telegram.

Subscribe to our YouTube channel.

Go here to see the original:
Scientist says anti-epilepsy drug can be repurposed for Covid-19, writes to ICMR to test it - ThePrint

Text Size:A- A+

New Delhi: Over 20 research institutes are working overnight to develop vaccines for the treatment of the highly infectious novel coronavirus, said a top government official.

The National Institute of Virology (NIV), Pune, and the Indian Council of Medical Research (ICMR) are among these research institutes.

According to Renu Swarup, Secretary, Department of Biotechnology (DBT), which functions under the Ministry of Science and Technology, the government has received over 7,000 tech-based proposals from private companies and individuals across the country to fight Covid-19.

In an interview to ThePrint, Swarup further said the government is dealing with several aspects from scaling up production of low-cost Covid-19 testing kits and ventilators to expediting research for the development of vaccine to fight the novel coronavirus.

We are working on several aspects right now. First is scaling up the manufacturing capacity of those start-ups and incubators, who have made low-cost testing kits and ventilators. They got early approval from the NIV and ICMR also. Eight to nine companies are in the process to get approval for their kits and ventilators, said Swarup.

We are also supporting those companies who got approval for commercial production of testing kits and ventilators. Besides, all IIT-incubators have been asked to focus on research and development of portable ventilators, on genome sequencing and on isolation of the strain of the novel coronavirus from blood samples, she added.

Also read: How do you test for coronavirus? All you want to know about testing kits, process, results

Swarup said IIT-Kanpur and IIT-Roorkee incubation centers are working on making portable ventilators.

We are also supporting three indigenous companies in scaling up their manufacturing capacity of providing ventilators at a fast pace. A Mysuru-based firm is also ramping up its capacity to make more ventilators. It is working with the NITI Aayog, DBT, DRDO (Defence Research and Development Organisation) to manufacture more ventilators, she said.

The DBT is also supporting private companies to procure local components to manufacture ventilators because there is a problem in sourcing them from outside now (in the wake of the lockdown), she added.

An ICMR official told ThePrint ventilators and testing kits are extremely essential if the outbreak reaches the third stage.

India, with less than 1 lakh intensive care units and a bed ratio of 1:1,000, will be at risk if outbreak reaches the third stage. The unique nature of the disease requires 3-4 week of recovery and 21-day ventilator support, said the official.

Ventilators are the next level weapon after a test kit, which is required in sufficient numbers in case of a mass outbreak, he added.

Swarup said the coronavirus research consortium, which has experts from the ICMR, DBT, NIV, are working to develop a vaccine for Covid-19.

We are researching new molecules for treatment. We are researching repurposed drugs to treat patients. More than 45 drugs have been identified that may be effective and research is going on. Several DBT institutions are working to see which formulations can work effectively against Covid-19, she said.

We are also sharing our research with international consortium, which are working on vaccine development. But in any case, it will take time. They are at the animal trial stage and it will reach stage three of human trail not before year end, she added.

Over 7,000 technological solutions were received by the government as part of its COVID-19 Solution Challenge.

Under the initiative, individuals and companies can submit their tech-based ideas for strengthening the fight against coronavirus.

Several tech giants such as Microsoft, Intel, Amazon, Google have pitched ideas for making artificial intelligence-based solutions to detect suspected cases of coronavirus using the ICMR data. Ideas to manufacture low-cost ventilators, low-cost test kits and herbal sanitisers also came, the DBT secretary told ThePrint.

Swarup said all these ideas are being vetted.

A committee headed by K. VijayRaghavan, principal scientific adviser to the government, is evaluating the ideas and the DBT will support the selected research proposal, she added.

The DBT has also invited proposals from companies working in the field of research and development to manufacture ventilators, testing kits, for which it will provide the required funding, the DBT secretary added.

Also read: By failing to scale up testing coronavirus, India may have lost crucial time

ThePrint is now on Telegram. For the best reports & opinion on politics, governance and more, subscribe to ThePrint on Telegram.

Subscribe to our YouTube channel.

View original post here:
20 Indian institutes working to find Covid-19 vaccine, IITs focused on portable ventilators - ThePrint

Item 8.01 Other Events.

Green Vision Biotechnology Corp. (the "Company") hereby announces that it isrelying the order of the Securities and Exchange Commission, Release No.34-88318, dated March 4, 2020 for the extension of the filing deadline of itsAnnual Report on Form 10-K, for the year ended December 31, 2019. There was anoutbreak of Coronavirus in China at the end of January, 2020. In order to avoidthe risk of the virus spreading, the Chinese government required enterprises todelay the resumption of work and production, this included City lockdown, travelsuspension, operation suspension, 14-days quarantine, and the work from home.The Company has major operation in Jinzhong, Shanxi and abided by the governmentrule to suspend operation since late January 2020. This has hindered theprogress of performing audit procedures so as to express an appropriate auditopinion for the audit of the Company. Because of the government order to suspendoperation, the Company's accounting staff could not access to the physicalrecords of the Company which cause a delay in providing the relevant informationto the Company's independent public accountant so as to perform the requiredaudit procedures.

The delay to provide responses to auditor inquiries also effected thehardworking of the Company's management because it took more time to collect theappropriate information, access and locate relevant documents, and re-arrangevarious resources. The aforementioned and the subsequent delays relating to thecompletion of audit procedures have caused the filing of the Form 10-K on orbefore April 15, 2020 to become impossible. The Company expects to file theannual report on Form 10-K on May 15, 2020.

Item 9.01 Financial Statements and Exhibits.

Edgar Online, source Glimpses

The rest is here:
GREEN VISION BIOTECHNOLOGY CORP. : Other Events, Financial Statements and Exhibits (form 8-K) - marketscreener.com

At least five patients, including some doctors, have overcome the critical state of health in which they had fallen due to the coronavirus and been moved from the Intensive Care units to normal hospital wards, after undergoing an expensive treatment that is producing good results.

Of the patients who have responded adequately to treatment, there are four from Santiago: Dr. Daniel Rivera, president of the Board of Directors of the Unin Mdica Clinic, urologist Fausto Hernndez, ex-governor Jos Izquierdo and patient Juan Ramn. In Santo Domingo, the political leader of San Pedro de Macors, Senator Jos Hazim, while Dr. Felix Antonio Cruz Jiminin has presented significant improvement, although he is still in intensive care with mechanical respiration, admitted to the General Hospital of the Plaza de health.

The details were offered by the Minister of Public Health, Rafael Snchez Crdenas, on the eighth day of the virtual press conference to report the updates to the Covid-19.He said it is a non-over-the-counter medicine that is applied intravenously and is applied to critically ill patients with complicated pneumonia.

A drug used in the treatment of arthritis patients has been applied to these patients.It is tocilizumab, a biological medicine, which is supplied through the High-Cost Medicines Program of the Ministry of Public Health.

Tocilizumab (Actemra) is a biologic medication approved to treat rheumatoid arthritis (RA) in adults, polyarticular juvenile rheumatoid arthritis (JRA), and the systemic form of juvenile idiopathic arthritis (JIA) in children. It isused to suppress the immune system in autoimmune diseases.

Biological drugs are artificial and manufactured using genetic engineering techniques and are closely related to a protein that the body produces naturally.

Dr. Snchez Crdenas reported that there are nine doctors registered with the virus, of whom four were in the process of their work, and others were infected on a cruise or airplane trip, and about three nurses.

He recalled that the highest risk of death is in people over 60 years old and people with co-morbidities, so he called people to take more extreme care of older adults.

Cross-testsThe Minister of Public Health, Rafael Snchez Crdenas, announced that from yesterday the trial would begin with cross-tests at the Dr. Defill National Laboratory, in order to speed up the confirmation of Covid-19 cases.

THE PROCESSSnchez Crdenas revealed that starting today, Saturday, rapid tests of up to 15 minutes will be made, through blood collection obtained from the pulpejo, with patients who have tested positive for other types of tests, to confirm their effectiveness, and then put them into service.

The testsThe effectiveness of rapid tests can be as high as 95%, and the PCR tests, which are being applied in the laboratory, are a specific test with 95% effectiveness, said Crdenas.Those 15-minute rapid tests, of which there are already samples in the country, will be tested today with patients.

Continued here:
Treatment gets five out of Intensive Care - Dominican Today

Cutting Equipment Market Scope of the Report:

The global market for Cutting Equipment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2029, from xx million US$ in 2018, according to a new study. This report focuses on the Cutting Equipment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The research report studies the Cutting Equipment Marketusing different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.

ThisPress Release will help you to understand the Volume, growth with Impacting Trends. Click HERE To get SAMPLE PDF (Including Full TOC, Table & Figures) at https://www.xploremr.com/connectus/sample/337

The report offers the market growth rate, size, and forecasts at the global level in addition as for the geographic areas: Latin America, Europe, Asia Pacific, North America, and Middle East & Africa. Also, it analyses, roadways and provides the global market size of the main players in each region. Moreover, the report provides knowledge of the leading market players within the Cutting EquipmentMarket. The industry-changing factors for the market segments are explored in this report. This analysis report covers the growth factors of the worldwide market based on end-users.

In accordance with a competitive prospect, this Cutting Equipmentreport dispenses a broad array of features essential for measuring the current Cutting EquipmentMarket performance along with technological advancements, business abstract, strengths and weaknesses of market position and hurdles crossed by the leading Cutting EquipmentMarket players to gain leading position. Other aspects such as customer base, sales reach, local coverage, production price trends, and production cost layout are also analyzed to bestow accurate rivalry perspective.

Pivotal highlights of Cutting EquipmentMarket:

Get Your Copy at a Discounted Rate!!! Limited Time Offer!!! https://www.xploremr.com/connectus/check-discount/337

The report covers exhaustive analysis on:

Geographically, this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate ofCutting Equipment in these regions, from2017 2025 (forecast), covering

Benefits of Purchasing from XMR:

Get Full Report Access athttps://www.xploremr.com/cart/337/SL

About Us

XploreMR, a leading market research firm, headquartered in San Jose, USA, XploreMR has, in a short span of time, served the market research needs of some of the biggest Fortune 500 companies. XploreMR also has highly personalized market research offerings for SMEs, and we pride ourselves on being uniquely positioned to have worked with colossal multinational firms and small, boutique firms. Our experience of working with such a diverse set from all over the world has given us invaluable perspectives on objectives, outlooks, goals, and eventually, the collective, symbiotic growth that stakeholders across the value chain aspire for. We keep these perspectives and aspirations in mind every time we work on a project, and this motivates us to exceed client expectations on a consistent basis.Contact us:

XploreMR111 North Market Street, Suite 300,San Jose, CA 95113, United StatesPh.No: +16692840108E-mail id-[emailprotected]Web-https://www.xploremr.com

Read more from the original source:
Rheumatoid Arthritis Diagnosis Tests Market to Witness Comprehensive Growth by 2017 2025 - Daily Science

With the rise in number of opioid addictions, alternative long-term care and acute flare management for gout should be further addressed, according to a letter to the editor published in Arthritis Care & Research.1

Researchers previously reported on the diagnosis and treatment of acute gout flares in a 541 consecutive emergency department (ED) visits over a 7-year period.2 They indicated that among patients who visited the ED for an acute gout flare, 35% received an opioid (oxycodone/acetaminophen) and 52% received a prescription for an opioid. According to another study, opioids were prescribed more than 50% of the time in the ED for acute gout flares3; however, the researchers pointed out that the use of analgesia alone does not treat gouty inflammation.

Researchers of this study noted that treatment programs need to consider that gout is a long-term, chronic disease that requires continuous management; the possibility that acute flare-ups can occur must be considered. Research is necessary to address if the use of opioids for acute gout flares in the ED is warranted as well as to establish evidence-based guidelines for treating gout flares.

[T]he clinical importance of this study is that it will increase discussion about the treatment of acute gout flares in the ED and beyond, the investigators concluded.

Disclosure: Several study authors declared affiliations with the pharmaceutical industry. Please see the original reference for a full list of authors disclosures.

References

1. Schlesinger N, Brunetti L. Treatment of acute gout flares in the emergency department [published online February 14, 2020]. Arthritis Care Res (Hoboken). doi:10.1002/acr.24166

2. Oster A, Bindman AB. Emergency department visits for ambulatory care sensitive conditions: insights into preventable hospitalizations. Med Care. 2003;41:198-207.

3. Dalal DS, Mbuyi N, Shah I, Reinert S, Hilliard R, Reginato A. Prescription opioid use among acute gout patients discharged from the emergency department [published July 2, 2019]. Arthritis Care Res. doi:10.1002/acr.23928

Follow this link:
Evaluating the Treatment of Acute Gout Flares in the Emergency Department - Rheumatology Advisor

For the past two weeks now, weve been talking about hydroxychloroquine as the wonder drug in the fight against the deadly coronavirus. Two anti-malaria drugs hydroxychloroquine and chloroquine are shown to be effective in treating COVID-19 patients after controlled clinical study conducted by doctors in France shows that a combo of Hydroxychloroquine and Azithromycin (Z-Pak) cures 100% of coronavirus patients within 6 days of treatment.

However, according to doctors treating coronovirus patients in Italy, Tolicizumab, a drug used to treat moderate to severe rheumatoid arthritis, has been shown to be more effective than hydroxychloroquine.Tolicizumab is so effective that the FDA gives green lights to Phase III Tocilizumab Trial for COVID-19 pneumonia. In a related report, Italian doctors said that a 101-year-old Italian man who survived the 1918 Spanish flu pandemic and World War II, recovered from COVID-19.

In another report, scientists claim Tocilizumab has been shown to help cure 95 percent of critically ill coronavirus patients in China. Tocilizumab, which is marketed as Actemra, is taken by patients with rheumatoid arthritis toreduce inflammation.Chinese doctors gave it to 20 patients during the peak of of coronavirus epidemic.Nineteen of the patients were discharged within 14 days despite being critically ill.Actemra has now been approved for use in China and for trials in the US

In response to a question from another doctor on hydroxychloroquine, Dr. Giusppe Galati, an Italian doctor, said in a tweet: Dear@DrLuizSilva1despite the large noise on social media. Here in Flag of Italy they are trying several combinations of antiviral included the combination HCQ + azithro. Infectivologist refer little benefit. The unique drug which is causing impressive improvement is#Tolicizumab.

Tocilizumab, also known as atlizumab, is an immunosuppressive drug, mainly for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis, a severe form of arthritis in children. It is a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R).

Dear @DrLuizSilva1 despite the large noise on social media. Here in ?? they are trying several combinations of antiviral included the combination HCQ + azithro. Infectivologist refer little benefit. The unique drug which is causing impressive improvement is #Tolicizumab

— Giuseppe Galati (@GiuseppeGalati_) March 20, 2020

Dear Giuseppe @GiuseppeGalati_ Are the patientes being treated with HCQ an Azithronycin in Italy ? What are the results? Do you start these medicarions as soon as the symptoms begin or late in the courso of disease ?

Dr. Luiz Silva (@DrLuizSilva1) March 20, 2020

The FDA approved the double-blind, randomized phase III clinical trial of the oncology supportive care drug tocilizumab (Actemra) for use in combination with standard of care for the treatment of hospitalized adult patients with severe COVID-19 pneumonia, according to Genentech (Roche), the manufacturer of the interleukin-6 receptor antagonist.

Genentech is also working with the Biomedical Advanced Research and Development Authority (BARDA), a part of the US Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR), to evaluate tocilizumab combined with standard of care versus placebo plus standard of care. In a press release,Genentech said it is providing 10,000 vials of tocilizumab to the United States Strategic national stockpile for potential future use as determined by the US Department of Health and Human Services.

We thank the FDA for rapidly expediting the approval of this clinical trial to evaluate Actemra in critically ill patients suffering from pneumonia following coronavirus infection and were moving forward to enroll as quickly as possible, Alexander Hardy, chief executive officer of Genentech, said in the press release.

Conducting this clinical trial in partnership with BARDA and providing Actemra to support the national stockpile, through the efforts of Secretary Azar and HHS, are important examples of how the US government the biotechnology industry and healthcare communities are working together in response to this public health crisis, added Hardy.

See the original post:
BREAKING: Tolicizumab (Actemra) shown to be more effective than hydroxychloroquine in treating coronavirus patients, Italian doctors say -...

New Jersey, United States:The Veterinary Medicine Market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the Veterinary Medicine market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the Veterinary Medicine Market. With qualitative and quantitative analysis, we help you with thorough and comprehensive research on the Veterinary Medicine market. We have also focused on SWOT, PESTLE, and Porters Five Forces analyses of the Veterinary Medicine market.

Leading players of the Veterinary Medicine market are analyzed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. We also provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the Veterinary Medicine market. Furthermore, the report offers two separate market forecasts one for the production side and another for the consumption side of the Veterinary Medicine market. It also provides useful recommendations for new as well as established players of the Veterinary Medicine market.

Veterinary Medicine Market by Regional Segments:

The chapter on regional segmentation describes the regional aspects of the Veterinary Medicine market. This chapter explains the regulatory framework that is expected to affect the entire market. It illuminates the political scenario of the market and anticipates its impact on the market for Veterinary Medicine.

Analysts who have authored the report have segmented the market for Veterinary Medicine by product, application and region. All segments are the subject of extensive research, with a focus on CAGR, market size, growth potential, market share and other important factors. The segment study provided in the report will help players focus on the lucrative areas of the Veterinary Medicine market. The regional analysis will help the actors to strengthen their position in the most important regional markets. It shows unused growth opportunities in regional markets and how they can be used in the forecast period.

Ask for Discount @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=21894&utm_source=SGN&utm_medium=003

Highlights of TOC:

Overview: In addition to an overview of the Veterinary Medicine market, this section provides an overview of the report to give an idea of the type and content of the study.

Market dynamics: Here the authors of the report discussed in detail the main drivers, restrictions, challenges, trends and opportunities in the market for Veterinary Medicine.

Product Segments: This part of the report shows the growth of the market for various types of products sold by the largest companies.

Application segments: The analysts who have authored the report have thoroughly evaluated the market potential of the key applications and identified the future opportunities they should create in the Veterinary Medicine.

Geographic Segments: Each regional market is carefully examined to understand its current and future growth scenarios.

Company Profiles: The top players in the Veterinary Medicine market are detailed in the report based on their market share, served market, products, applications, regional growth and other factors.

The report also includes specific sections on production and consumption analysis, key results, key suggestions and recommendations, and other issues. Overall, it offers a complete analysis and research study of the Veterinary Medicine market to help players ensure strong growth in the coming years.

Complete Report is Available @ https://www.verifiedmarketresearch.com/product/Veterinary-Medicine-Market/?utm_source=SGN&utm_medium=003

About us:

Verified market research partners with the customer and offer an insight into strategic and growth analyzes; Data necessary to achieve corporate goals and objectives. Our core values are trust, integrity and authenticity for our customers.

Analysts with a high level of expertise in data collection and governance use industrial techniques to collect and analyze data in all phases. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research reports.

Contact us:

Mr. Edwyne FernandesCall: +1 (650) 781 4080Email: [emailprotected]

Tags: Veterinary Medicine Market Size, Veterinary Medicine Market Trends, Veterinary Medicine Market Forecast, Veterinary Medicine Market Growth, Veterinary Medicine Market Analysis

Our Trending Reports

Intelligent Pigging Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Go here to see the original:
Veterinary Medicine Market 2020 | Growing Rapidly with Significant CAGR, Leading Players, Innovative Trends and Expected Revenue by 2026 - Skyline...

DEAR ABBY: My husband barely speaks to me. We both work full time and are facing the empty nest very soon. At home, I have to initiate even the smallest of small talk. He'll never say "Good morning" or ask "How was your day?" Although I work hard to keep the house the way he likes it, he speaks up only to criticize the few times I don't meet his standards. There's never a word of acknowledgment when I have accomplished other elements of housekeeping.

When I laugh at the Sunday comics, he doesn't even ask what's funny. As a result, I have become defensive. Then he accuses me of being "dismissive of his feelings." He says I don't communicate with him, but when I do, he barely responds, so over the years I have basically shut down. We have been to counseling, and maybe it's time to go again. Do you have any perspective to offer?

UNACKNOWLEDGED IN THE SOUTH

DEAR UNACKNOWLEDGED: It is definitely the right move to return to counseling. But when you do, this time speak up for yourself loud and clear. If you do, it may change the dynamics of your relationship because when he accuses you of not communicating, he is blaming the victim. Once you have said your piece, let the marriage and family therapist mediate what is certain to be a long-overdue discussion.

DEAR ABBY: I am a 25-year-old man currently dating a 39-year-old woman. We have been dating for 2 1/2 months. We have talked about our age difference a couple of times, but apart from that issue, every other aspect of our relationship is going well, including communication, intimacy and maturity.

We are not super interested in having children, and we both have expressed interest in adopting a child if we were to have one somewhere down the line. Despite this, I have heard from family (my parents, mostly) and close friends that I'm making a terrible mistake by dating a woman so much older.

They say it is not practical to marry a woman so much older because it will present major health and aging challenges as time goes by. This is the argument that most influences my feelings. Should I break up with her and tell her that the age difference is the reason? I feel I should decide soon so as not to waste her time.

NOT JUST A NUMBER IN SAN FRANCISCO

DEAR NOT JUST A NUMBER: You have been seeing this woman for only 2 1/2 months. The relationship is still new. That you are discussing marriage and children seems to me to be premature. My advice is to slow down. Let time dictate whether this romance develops further.

Discuss the flak you are getting from your parents with your lady friend. But the 14-year age difference does not necessarily mean that she'll have health challenges that you won't. Decide together whether the age difference is a deal-breaker.

DEAR ABBY: This may seem like a strange question, but my husband says our 6-year-old cat, "Taffy," is really 42 years old. He says one cat year equals seven people years. Taffy is like a baby to me. What gives?

NEVER HEARD THAT IN NEVADA

DEAR NEVER HEARD: Your husband is right. As you may have already noticed, humans have longer lives than dogs and cats, but pets mature faster. According to veterinary medicine, the first two years of a cat's life equal 25 human years. After that, every cat year equals four human years. This would make Taffy the ripe old age of 41 or 42. If this is shocking to you, remember that 42 is the new 22.

Read the original:
Marriage crumbling as couple's communication becomes bitter - News from southeastern Connecticut - theday.com

Ally the dachshund has chronic pancreatitis thatrequires daily care.

Its special veterinarian-assisted care that her owner is worried might not be available when she needs it most due to the ongoing COVID-19 outbreak.

Shes on strict food and thats the only thing shes allowed. Shes allowed no treats, no human food, no nothingand insulin twice a day, said Marisa Panter. She cant have a different kind of food, the food is bought from a vet office. She cant have a different kind of insulin, and the insulin is bought from a vet office.

Panter and 7-year-old Ally live outside of Kelowna, along with her three-year-old daughter, 13-year-old step-son, her husband, her in-laws, and six pregnant dachshunds that Panter is breeding.

Ally loves all dogs and humans she meets. Shes visited hospitals and retirement homes, bringing joy to residents and patients, and is inseparable from Panters daughter.

Shes probably done 500,000 km in a vehicle, if we go anywhere and were not going to be home for insulin, we have to take her with us, she said

Like most veterinarian clinics, Panters vet clinic has closed its doors to all non-essential visits and has resorted to parking lot pickups for food and medication.

She shares a common concern with many pet owners during this time will she be able to get the adequate care she needs when so many services are being cut back?

If her pancreatitis acts up, she needs to be in a (clinic) for three days on IV, she said. If theres no vets, I watch her die.

Dr. Chris Armstrong, a veterinarian and member of the Canadian Veterinary Medical Associations (CVMA) Council, said the one of the main things pet owners should keep in mind is that vet clinics have been declared essential in many provinces and theres no sign of them shutting down in British Columbia.

READ MORE: B.C. vet stresses need for pet hygiene despite COVID-19 risk being low

READ MORE: More information needed after dogs weak positive COVID-19 test result: expert

It may not be business as usual, but I think certainly pet owners and animal owners should not be afraid that their animals wont be taken care of, she said. Particularly in emergency or urgent situations.

Virtual care options are also starting to become available GoFetch Health recently launched a Canada-wide service that can help pet owners connect with vets to ask questions and get advice on if their animal needs further care.

The CVMA put out a statement on March 24 advising vets on best practices for telemedicine. However, Armstrong said there is a big worry in her industry: running out of medical supplies.

Veterinarians, like human medicine, were running out of masks, were running out of surgical gloves, were running out of personal protection equipment, she said.

Armstrong said that puts limits on things like non-essential surgeries, like a neutering or spaying.

I think thats really one of the biggest limiting factors is: can we access sufficient masks and gloves and gowns to be able to continue service?

When it comes to another common worry, running out of medicine, Armstrong said that hasnt been a problem so far. She urges pet owners to resist hoarding because that would start to affect supply.

For most of the medications, I think certainly the supply chain is still there, she said. Hoarding at least for pet owners goes just as true for medications and products.

Armstrong said people have also been worried about their pets contracting COVID, which she said is very unlikely. Theres also been no proof that humans can contract COVID from their pets.

There has only been two COVID positive dogs, theres been a tremendous number of dogs been tested through IDEX, which is one of our labs, she said. And out of all the testing, its only the two Hong Kong dogs.

However, Armstrong said its worth remembering that pets can carry COVID, much like any other surface.

Dogs, like your pen or a table, could act as what we call a fomite, she said. So, in other words, a COVID positive person kissed their dog on the head, just like if they kissed their pen, could they put the virus on those two objects? And the answer is, yes.

New information comes forward all the time, said Armstrong, and the best thing pet owners can do is stay up to date from reliable sources.

I think that the message to go across is that, if we are patient, if we kind of know that this is a fluid situation, take direction from responsible and reliable sources, she said.

Stay calm and be nice.

cloe.logan@pqbnews.com

Like us on Facebook and follow us on Twitter

AnimalsCoronavirus

See original here:
B.C. veterinarians want to smooth the fur of COVID-19-worried pet owners - Coast Mountain News

Horse racing at Golden Gate Fields, Albany, California. Photo: Noah Salzman CC BY-SA 4.0, via Wikimedia Commons

A major US study will explore the effects of a combination of two drugs that may be contributing to catastrophic injuries and cardiac issues in racehorses.

Researchers at the University of Pennsylvanias New Bolton Center, part of the School of Veterinary Medicine, will carry out a multidisciplinary study exploring combined usage of furosemide, commonly known as Lasix, and bisphosphonates in horses.

It will be the first comprehensive analysis of the two drugs that, when used concurrently could be capable of diminishing bone integrity and compromising cardiac function in racehorses. These effects have the potential to contribute to catastrophic injuries on the racetrack.

The beauty of this study is that it will use a multi-disciplinary approach to assess the interaction between these two drugs that we know are administered to racehorses, says Dr Mary Robinson, assistant professor of veterinary pharmacology and director of the Equine Pharmacology Laboratory at the New Bolton Center.

By coupling our state-of-the-art imaging technologies with the scope of expertise among the other investigators on this project, we will be able to produce solid, unbiased data that will address some of the unknowns surrounding the use of these medications.

Nearly 85 percent of racehorses in the United States receive Lasix as a preventive therapy for a condition called exercise-induced pulmonary hemorrhage (EPIH), or bleeding into the lungs.

Also used in human medicine to treat heart conditions, the drug is known to cause a short-term loss of calcium and increase the risk of fractures in human patients.

But because horses can quickly recover from a calcium deficit, Lasix alone is unlikely to be the root cause for catastrophic, racing-related breakdowns which, according to The Jockey Club Equine Injury Database, occur at a rate of about 1.6 per 1000 starts.

A team comprised of 13 researchers from the vet school will explore the largely unknown effects of a class of drugs called bisphosphonates, particularly when being used with Lasix.

Intended to preserve the integrity of bone, bisphosphonates are commonly used in elderly patients to treat osteoporosis. When administered to young, growing animals, however, the drug may have adverse effects by preventing bone from properly adapting to the forces applied during training such as those experienced when a horse is at a gallop.

Because bisphosphonates can linger in the bone for at least one year after the administration of a single dose, there is a heightened chance for interaction with Lasix in horses who are undergoing training.

Bisphosphonates have also been associated with increased risks of heart conditions in humans, including atrial fibrillation, ventricular arrhythmias, and alterations in heart rate variability.

The research team will cross-examine other facets related to the use of these substances in racehorses, including pioneering new understandings of advanced imaging systems such as New Bolton Centers standing robotic computed tomography (CT) and, in collaboration with Dr Mathieu Spriet, from the University of California, Davis, a new standing positron emission tomography (PET) system.

The system, which is identical to the one already in place at Santa Anita Park, will make the New Bolton Center the second veterinary hospital in the world to implement the use of an equine PET scanner.

This amazing imaging technology is going to be really instrumental in helping us assess the effects or lack thereof of these drugs on the bone, Robinson says.

It is the most sensitive technique that we have, from an imaging perspective, to look in detail at a horses legs and see whats going on metabolically.

The New Bolton Centers Kathryn Wulster says the technology will enable researchers to definitively note any changes in bone turnover in areas as precise as two square millimeters.

But the real beauty of using both the PET scan and our robotic CT system in tandem is that we can confidently identify any present morphologic or shape abnormalities within the bone that we know could predispose a horse to fracture, Wulster says.

Together, theyre going to give us a remarkable amount of information about what is or isnt going on in these horses.

The research team will also be accumulating findings into an innovative, data-driven platform that will be invaluable to objectively assess national trends in racehorse related injuries.

Researchers at the vet school will also explore Extracellular Vesicle Cores (EVs) in blood or other samples to detect illicit use of bisphosphonates, which are presently undetectable in the blood of a horse after 30 days.

EVs are membrane-enclosed nanoparticles released from all cell types and play an integral role in intercellular communication. Because they possess tissue-specific characteristics representative of the cells in which they came from, they hold the potential to provide non-invasive, rapid diagnostic solutions to test for the presence of illegitimate drug use.

Dr Andrew Hoffman, dean of Veterinary Medicine and principal investigator of the EV Core Facility, describes the field of EV research as a vastly promising and explosive area of study.

By harnessing the unique communicative power of EVs, we hope to redefine how we can utilize blood samples in order to proactively safeguard the health and well-being of these tremendous athletes, he says.

Beyond detecting illegitimate substance use, these biomarkers also offer the means of identifying otherwise indiscernible, but significant, changes in the horses biological health that could serve as warning signs of an increased risk for catastrophic injury.

Robinson adds: Our hope is to eventually harness the information carried in these vesicles to develop a hand-held, stall-side diagnostic tool that could be used on race day to make sure horses are healthy enough to compete safely, as well as by trainers in the field to continuously evaluate any changes in their horses well-being, and when additional veterinary care may be needed.

The study is expected to take two years to complete.

It will, says Robinson, provide the most comprehensive data available to assess if the use of these substances may or may not be contributing to catastrophic injuries on the track.

At the end of the day, were dedicated to ensuring we are doing everything in our power to provide owners, breeders, and trainers with sound, unbiased insights to keep their horses safe.

Robinson is an assistant professor of veterinary pharmacology and director of the Equine Pharmacology Laboratory at the University of Pennsylvania School of Veterinary Medicine.

Additional investigators on the study include Dr Kyla Ortved, Dr Cristobal Navas de Solis, Dr Claire Underwood, Dr Virginia Reef, Dr Darko Stefanovski, Dr Rachel Derita, Dr Joanne Haughan, Dr Youwen You, Dr Jinwen Chen and Dr Zibin Jiang, all with the universitys veterinary school.

This study is supported in part by Roy and Gretchen Jackson, George and Julia Strawbridge, and the Pennsylvania State Horse Racing Commission.

In other news, the board the Racing Medication and Testing Consortium (RMTC) has approved the funding of an unrelated study on bisphosphonates through its Tactical Research Grant Program. The research will be conducted at Cornell University under the direction of Dr Heidi Reesink.

This study is an important first step in answering questions about the prevalence and effect of bisphosphonates in the training and racing population, so that we can refine our strategies in protecting racehorse bone health, RMTC executive director Dr Mary Scollay says.

The RMTC consists of 23 racing industry stakeholders and organizations that represent Thoroughbred, Standardbred, American Quarter Horse and Arabian racing.

See the original post:
Study to explore whether a drug combination is harming horse bone health - Horsetalk

SYDNEY, N.S.

Veterinary care is now being deemed an essential service in Nova Scotia during the COVID-19 pandemic

Chief medical officer of health, Dr. Robert Strang, has asked for the province's Health Protection Act to be amended to include veterinarians.

Veterinarians have been asking the province to ensure their clinics can stay open during the COVID-19 outbreak to deal with sick and injured animals.

When Nova Scotia declared a state of emergency in an effort to reduce the spread of the virus, veterinary medicine wasnt listed as an essential service.

Even before Premier Stephen McNeil announced the state of emergency, the Nova Scotia Veterinary Medical Association had directed the approximately 100 animal hospitals and clinics it represents including 13 in Cape Breton to take measures to prevent the spread of COVID-19.

The association says veterinarians in the province are trained in epidemiology and herd health, so they have been quick to implement protocols to reduce the spread of infection.

Read the original post:
Health Protection Act in Nova Scotia to be amended to include veterinary services - Cape Breton Post

According to Masud Soleimani, who recently came home from illegal detainment in US, the research is being carried out with the support of the Health Ministry in two Tehran-based hospitals of Shariati and Masih Daneshvari.

The news came as some local media had earlier quoted Soleimani as saying that a drug for the disease has been developed.

In an interview with Mehr News Agency on Saturday night, Soleimani dismissed the reports as inaccurate, noting that this is not a drug but a method that is still being worked on.

The results of the first phase of its clinical trial will be announced soon by the Health Ministry, he added.

According to the latest announcement on Saturday, the number of confirmed cases of the COVID-19 has hit 35,408 in the country. 11,679 patients have recovered so far while the virus has claims 2,517 lives.

MAH/ 4888035

See the original post here:
Iranian scientists working on stem cell therapy to treat Covid-19 patients - Mehr News Agency - English Version

LONDON--(BUSINESS WIRE)--The global autologous cell therapy market is poised to grow by USD 1.97 billion during 2020-2024, progressing at a CAGR of almost 22% during the forecast period. Request free sample pages

Read the 120-page report with TOC on "Autologous Cell Therapy Market Analysis Report by Therapy (Autologous stem cell therapy and Autologous cellular immunotherapies), Application (Oncology, Musculoskeletal disorders, and Dermatology), Geography (North America, APAC, Europe, South America, and MEA), and the Segment Forecasts, 2020-2024".

https://www.technavio.com/report/autologous-cell-therapy-market-industry-analysis

The market is driven by the increasing demand for effective drugs for cardiac and degenerative disorders. In addition, the limitations in traditional organ transplantations are fueling the demand for stem cell therapies. All these factors are anticipated to boost the growth of the autologous cell therapy market.

The demand for effective drugs for cardiac and degenerative disorders has been increasing across the world. In addition, the discovery of possible cardiac autologous cells has enabled vendors to develop novel drugs for the treatment of various cardiac diseases. For instance, Mesoblast is developing MPC-150-IM. It is a Phase III candidate for the treatment of advanced and end-stage chronic heart failure. Similarly, Shire has been developing autologous stem cell therapies for chronic myocardial ischemia. These products are expected to be launched during the forecast period and will have a positive impact on the growth of the global autologous cell therapy market.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Major Five Autologous Cell Therapy Market Companies:

Bayer AG

Bayer AG operates its business through segments such as Pharmaceuticals, Crop Science, Consumer Health, and Animal Health. The company offers induced pluripotent stem cells. They are developed by reprogramming mature body cells to behave like embryonic stem cells that are injected to restore diseased tissue in patients.

Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc. operates its business through an unified business segment. NurOwn is the key offering of the company. It is a cell therapy platform, which develops mesenchymal stem cells for the treatment of human diseases such as immune and inflammatory diseases.

Daiichi Sankyo Co. Ltd.

Daiichi Sankyo Co. Ltd. operates its business through segments such as Innovative Pharmaceuticals, Generic, Vaccine, and OTC Related. Heartcel is the key offering of the company. It is an immune-modulatory progenitor cell therapeutic agent, which is used for ischemic heart failure.

FUJIFILM Holdings Corp.

FUJIFILM Holdings Corp. operates its business through segments such as Imaging solutions, Healthcare and material solutions, and Document solutions. The company uses induced pluripotent stem cells to derive differentiated cells, which are used in researching various diseases and conditions.

Holostem Terapie Avanzate Srl

Holostem Terapie Avanzate Srl operates its business through an unified business segment. Holoclar is the key offering of the company. It is an advanced therapy medicinal product containing stem cells indicated to repair the cornea after injury.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

Autologous Cell Therapy Market Therapy Outlook (Revenue, USD Billion, 2020-2024)

Autologous Cell Therapy Market Application Outlook (Revenue, USD Billion, 2020-2024)

Autologous Cell Therapy Market Regional Outlook (Revenue, USD Billion, 2020-2024)

Technavios sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.

Request a free sample report

Related Reports on Healthcare Include:

Global Cancer Stem Cell Therapeutics Market Global cancer stem cell therapy market by type (allogeneic stem cell transplant and autologous stem cell transplant) and geography (Asia, Europe, North America, and ROW).

Global Mantle Cell Lymphoma Therapeutics Market Global mantle cell lymphoma therapeutics market by product (combination therapy and monotherapy) and geography (Asia, Europe, North America, and ROW).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Link:
Global Autologous Cell Therapy Market 2020-2024 | Evolving Opportunities with Bayer AG and Brainstorm Cell Therapeutics Inc. | Technavio - Business...

It is a universally acknowledged fact that the majority of women refuse to age, the moment they reach the age of 40. The desire to turn back the clock is something that gets automatically etched on their minds, after hitting middle age. Making a wise choice from the wide range of anti-ageing solutions available for women can be a highly baffling affair, but understanding the skins needs is equally crucial.

So what exactly is ageing, that every person, especially women dread? It can be regarded as a complex process resulting in accrual changes in a persons body over. a period of time. Ageing occurs in fractions, because the stem cells which have the ability to renew themselves grow old as DNA gets damaged and changes occur in the overall physiology. As time passes by and people age, the majority of the cells present in their bodies get replaced and the ability of the body to produce more new cells gradually declines, Thus, anti-ageing retards the degeneration process of the body.

Post an anti-ageing fat stem cell treatment the skin shows prominent signs of turning softer while the body notices a remarkable surge of energy, resulting in improved sleeping and breathing patterns, controlled sugar levels, rebalanced hormones, increased metabolism, average weight loss and fading age spots. This all seems possible owing to the insertion of 30-50 million supercharged active stem cells.

Ageing is indeed complex, as its causes have not yet been completely understood. A big part of ageing occurs when the body is being attacked by inflammation and oxidative stress. Even though it is said that ageing is a natural process which is unavoidable, there is still scope to maintain health and stay young for both preventing age-related diseases and to enjoy the benefits of youth.

The desire to be younger is not exactly a new idea. The concept of anti-ageing has kept humankind occupied since ages, with the idea about staying healthy and fit with age and improving the quality of life. So with the rising evidence about the association of ageing diseases with adult stem cell exhaustion, it will not be surprising to witness an elevation of interest towards restoring the adult stem cell function to improve these conditions and to turn back the clock!

Read the rest here:
Reversing The Ageing Process With Stem Cell Therapy - Version Weekly

New Jersey, United States:The Stem Cell Therapy Market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the Stem Cell Therapy market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the Stem Cell Therapy Market. With qualitative and quantitative analysis, we help you with thorough and comprehensive research on the Stem Cell Therapy market. We have also focused on SWOT, PESTLE, and Porters Five Forces analyses of the Stem Cell Therapy market.

Global Stem Cell TherapyMarketwas valued at USD 86.62 million in 2016 and is projected to reach USD 221.03million by 2025, growing at a CAGR of 10.97% from 2017 to 2025.

Leading players of the Stem Cell Therapy market are analyzed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. We also provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the Stem Cell Therapy market. Furthermore, the report offers two separate market forecasts one for the production side and another for the consumption side of the Stem Cell Therapy market. It also provides useful recommendations for new as well as established players of the Stem Cell Therapy market.

Stem Cell Therapy Market by Regional Segments:

The chapter on regional segmentation describes the regional aspects of the Stem Cell Therapy market. This chapter explains the regulatory framework that is expected to affect the entire market. It illuminates the political scenario of the market and anticipates its impact on the market for Stem Cell Therapy.

Analysts who have authored the report have segmented the market for Stem Cell Therapy by product, application and region. All segments are the subject of extensive research, with a focus on CAGR, market size, growth potential, market share and other important factors. The segment study provided in the report will help players focus on the lucrative areas of the Stem Cell Therapy market. The regional analysis will help the actors to strengthen their position in the most important regional markets. It shows unused growth opportunities in regional markets and how they can be used in the forecast period.

Ask for Discount @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=24113&utm_source=SGN&utm_medium=003

Highlights of TOC:

Overview: In addition to an overview of the Stem Cell Therapy market, this section provides an overview of the report to give an idea of the type and content of the study.

Market dynamics: Here the authors of the report discussed in detail the main drivers, restrictions, challenges, trends and opportunities in the market for Stem Cell Therapy.

Product Segments: This part of the report shows the growth of the market for various types of products sold by the largest companies.

Application segments: The analysts who have authored the report have thoroughly evaluated the market potential of the key applications and identified the future opportunities they should create in the Stem Cell Therapy.

Geographic Segments: Each regional market is carefully examined to understand its current and future growth scenarios.

Company Profiles: The top players in the Stem Cell Therapy market are detailed in the report based on their market share, served market, products, applications, regional growth and other factors.

The report also includes specific sections on production and consumption analysis, key results, key suggestions and recommendations, and other issues. Overall, it offers a complete analysis and research study of the Stem Cell Therapy market to help players ensure strong growth in the coming years.

Complete Report is Available @ https://www.verifiedmarketresearch.com/product/Stem-Cell-Therapy-Market/?utm_source=SGN&utm_medium=003

About us:

Verified market research partners with the customer and offer an insight into strategic and growth analyzes; Data necessary to achieve corporate goals and objectives. Our core values are trust, integrity and authenticity for our customers.

Analysts with a high level of expertise in data collection and governance use industrial techniques to collect and analyze data in all phases. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research reports.

Contact us:

Mr. Edwyne FernandesCall: +1 (650) 781 4080Email: [emailprotected]

Tags: Stem Cell Therapy Market Size, Stem Cell Therapy Market Trends, Stem Cell Therapy Market Forecast, Stem Cell Therapy Market Growth, Stem Cell Therapy Market Analysis

Our Trending Reports

Laser Pointer Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Read the original:
Stem Cell Therapy Market 2020 | Growing Rapidly with Significant CAGR, Leading Players, Innovative Trends and Expected Revenue by 2026 - Skyline...

The electronic newsletter I Love My Freedom on a regular basis blasts out e-mails hawking ostentatious rip-offs as well as serpent oil, such as a dementia-reversing miracle therapy, a diabetes destroyer material as well as a life-saving cancer cells treatment that a Nazi drug store allegedly established at Hitlers command. Peppered in between these messages funded by third-party hucksters are main advertisements from Donald Trumps governmental reelection campaign.

For months, participants of the head of states internal circle consisting of Donald Trump Jr., Senate Majority Leader Mitch McConnell (R-Ky), previous House Speaker Newt Gingrich as well as also Trump himself have actually been releasing require contributions with the newsletter, which usually heads out 5 or even more times each day. Many receivers were most likely unintentionally subscribed; I Love My Freedom, the team that runs the eponymous newsletter, has actually obtained an expanding checklist of Americans call info with a concealed e-mail collecting system including an internet of pro-Trump Facebook web pages.

Right- wing political leaders, companies as well as media electrical outlets have a background of dealing with unethical entities behind the scenes to earn money as well as press their programs. The Trump campaigns service with I Love My Freedom is no exemption.

I Love My Freedom (e-mail information multiplied by HuffPost).

By layout, its e-mails seem theyre sent out straight from Trump as well as his allies, though theyre in fact dispersed by means of [emailprotected] At all-time low, they birth please notes noting they were spent for by either the National Republican Senatorial Committee, its House equivalent, the McConnell Senate Committee, or the Trump Make America Great Again Committee (which is collectively run by the Republican National Committee as well as Trumps reelection campaign).

Renting out accessibility to collected e-mail listings is a typical as well as very profitable method worked out by traditional as well as liberal teams alike, commonly for political fundraising objectives. But points obtain morally dirty when e-mail representatives do not veterinarian their enrollers which can lead to e-mail receivers being flooded with ripoffs as well as scams, like the counterfeit cancer cells treatment. In this instance, nonetheless, the genuine inquiry is whether Trumps group troubled to veterinarian I Love My Freedom.

The campaign did not react to HuffPosts ask for remark.

I Love My Freedom, which makes up the newsletter as well as a conservative blog site called Trending Politics, belongs to Making Web LLC, a rare advertising company thats signed up in Minnesota to a 51- year-old male called Allan G. Ferretti.

Through the newsletter alone, I Love My Freedom has actually enhanced a list of aggressive rip-offs consisting of some that misleadingly link Trump, in spite of its negotiations with his campaign. Hours prior to dispersing a fundraising e-mail from the McConnell Senate Committee this month, I Love My Freedom discharged off a funded message advertising a breakthrough stem cell therapy which it baselessly suggested Trump is getting.

This has got Liberals jumping out of their seats, the e-mail checks out. President Trump is in perfect health how is it that hes so seemingly immune to old age? Well in recent years, billionaires like President Trump have increasingly turned to the power of Stem Cells.

Titled Trump Health Bombshell, the e-mail web links to a rambling item pitch that promotes $67 containers of stem cell tablets as the Holy Grail of aging backwards. These tablets make cells inside your body become physically younger, it asserts, without supplying a shred of clinical proof. I Love My Freedom has likewise spammed its customers with enrollers get-rich-quick plans consisting of a secret IRS loophole, as well as has actually routed them to video clips recommending elders ought to exchange their recommended medicines for tricksters supplements also advising that they can pass away if they do not.

Recent newsletter versions have actually circulated actual phony information, as well, installing advertisements camouflaged as write-ups that connect to internet sites stealthily copying genuine media electrical outlets.

I Love My Freedom e-newsletters have actually included misleading advertisements resulting in phony information websites copying genuine electrical outlets..

One such advertisement includes the message Royal Family Mourns As Tragedy Is Confirmed, along with a picture of Meghan Markle, the Duchess ofSussex Clicking on it causes a web site imitating U.S.A. Today that goes crazy regarding a skin care line, which it incorrectly asserts Markle released. Another, birthing the heading [BREAKING NEWS] Prayers Go Out to Oprah Winfrey, web links to a fraudulent information website marketing a Brain Booster supplement, which it brazenly states is in charge of Winfreys occupation success.

In enhancement to Trump, his oldest kid, McConnell as well as Gingrich, I Love My Freedom has actually likewise sent fundraising e-mails in behalf of previous White House press assistant Sarah Huckabee Sanders, House Minority Leader Kevin McCarthy (R-Calif), House Republican Whip Steve Scalise (R-La), previous United Nations Ambassador Nikki Haley,Rep Elise Stefanik (R-N.Y.),Rep David Joyce (R-Ohio), previous White House Deputy Chief of Staff Karl Rove as well as National Republican Congressional Committee Chairman TomEmmer

All were spent for by the NRCC, NRSC, McConnell Senate Committee or the Trump Make America Great AgainCommittee Only the NRCC reacted to an ask for remark.

We rented this list to prospect new donors. We do our best to vet each vendor, but similar to renting a car, it is impossible to know or control what every other renter does with a list they too are renting, spokesperson Chris Pack informed HuffPost.

We will not be using this vendor going forward.

I Love My Freedom constructed its cash-cow e-mail realm by spending virtually $2 million right into Facebook advertisements, which attract individuals in with clickbait surveys or pledges of free MAGA equipment, as well as result in web pages advising them to send their e-mail addresses. This immediately indications them as much as obtain the newsletter, in addition to its numerous funded messages.

The team likewise earns money by marketing Trump- themed product such as Make Liberals Cry Again hats, as well as organizing third-party advertisements on Trending Politics which was seen a million times last month alone, according to electronic analytics device ComparableWeb

I Love My Freedom did not accept HuffPosts ask for a meeting.

I Love My Freedom makes use of clickbait Facebook advertisements to gather individualss e-mails, after that subscribes them to its newsletter.

Ferretti released ilovemyfreedom.org in addition to the Facebook web page Trump for President Fan Club (currently President Donald Trump Fan Club, which has 1.6 million fans) in the summertime of 2015, as reporter April Glaser reported last loss in a write-up regarding I Love My Freedoms viral development on Facebook.

Its among greater than a lots preferred web pages the team runs to run its countless Facebook advertisements, consisting of Donald Trump Is My President, Donald Trump 2020 Voters, President Trump Has My Vote, Donald Trumps Americans, Team Trump Fan Club, The President Trump Fan Club, We Need Trump 2020 as well as President Trumps Patriot Army.

These web pages create a stream of hyper-partisan memes as well as Trending Politics post to their target market of millions. Boosted by Facebooks formula, the advertisements which largely target elders are in some cases seen thousands of countless times each.

This looks like an operation thats got a very highly engaged audience that would be a prime target for a lot of conservative politicians to try to raise grassroots money from, stated Michael Beckel, research study supervisor at the political reform team Issue One.

When you run a pro-Trump Facebook team with greater than a million participants, that can make your [email] checklist an appealing possession.

Trumps campaign has actually currently gathered a citizen e-mail checklist thats so big it leases it out to outdoors celebrations. So why would certainly his group wish to fundraise with I Love My Freedoms checklist particularly provided the teams historical connections to grifters as well as scam artist?

Its type of striking that the Trump campaign is making a financial investment in [I Love My Freedoms] checklist, kept in mindBeckel But a t completion of the day, he stated, much more e-mails still means more potential voters or donors for them.

Calling all HuffPost superfans!

Sign up for subscription to come to be a starting participant as well as aid form HuffPosts following phase

Original post:
Donald Trump Is Using An Insanely Sketchy Newsletter To Find Campaign Donors - The Union Journal